Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 8001–8050 of 76387
On August 2, 2024, Charles J. Casamento and Terry Coelho resigned as members of the Board of the Company, effective immediately.
the Board approved the termination of (i) the employment agreement, dated October 8, 2019, by and between the Company and Chief Executive Officer James Sapirstein
On August 2, 2024, Charles J. Casamento and Terry Coelho resigned as members of the Board of the Company, effective immediately.
On August 1, 2024, Briggs Morrison, M.D. notified the board of directors (the “Board”) of Repare Therapeutics Inc. (the “Company”) of his decision to resign as a Class III director and as chair of the Science and Technology Committee of the Board, effective as of August 6, 2024.
On August 6, 2024, Kristy F. Heuberger tendered her resignation from her position as a member of the Board of Directors (the “Board”) of JLL Income Property Trust, Inc. (the “Company”), effective as of August 6, 2024.
On August 6, 2024, Fran Soistman notified the Company of his decision to retire from his position as the Company’s chief executive officer upon appointment of a successor, which is expected to occur by or before the end of the second quarter of 2025.
effective August 7, 2024, Mr. Kent Mouton resigned from the Board of the Company.
Mr. Loh filled the vacancy left by Mr. Peters and will complete the remainder of Mr. Peter’s Class II term.
On August 5, 2024, John Cavan, the interim Chief Executive Officer and Chief Financial Officer of Hepion Pharmaceuticals, Inc. (the “Company”) left the Company for personal reasons.
On August 5, 2024, Tang Siu Fung notified Blue Print Global, Inc. (“Blue Print”), a British Virgin Islands company and a wholly owned subsidiary of the Company of his resignation as the sole director of Blue Print.
On August 7, 2024, GEX Management, Inc. (the “Company”) announced that Joseph Frontiere will resign as a Board Director of GEX Management effective immediately.
On August 5, 2024, Stacy D. Nieuwoudt notified Independence Contract Drilling, Inc. (the “Company”) of her decision to resign effective August 16, 2024, from the Board of Directors.
our current CEO, Mr. Philip Horlock, will resign from the CEO position effective as of close of business on September 28, 2024.
On August 7, 2024, Drew Sievers and the Company mutually agreed that Mr. Sievers would separate from the Company as its Chief Operating Officer effective December 31, 2024.
Karim Temsamani notified the Company of his intent to resign as the Company’s Chief Executive Officer and as a member of the Board of Directors of the Company (the “Board”), each effective as of August 16, 2024
On August 2, 2024, Mark D. Hazel notified Fifth Third Bancorp (the “Company”) of his intent to retire as Executive Vice President and Controller of the Company, effective October 6, 2024.
Mr. Richards’ transition from his role as Executive Vice President, CFO and Treasurer is a termination without “Cause” pursuant to that certain Amended and Restated Employment Agreement
On August 1, 2024, Shaw Joseph notified European Wax Center, Inc. (the “Company”) that he would be resigning from the Company’s Board of Directors (“the Board”), effective immediately.
Accepting the voluntary resignation of Heinrich Dreismann from the Board effective August 1, 2024
In addition, on August 5, 2024, Jaume Pons, Ph.D., and Sophia Randolph, M.D., Ph.D., resigned as members of the Company’s Board.
In addition, on August 5, 2024, Jaume Pons, Ph.D., and Sophia Randolph, M.D., Ph.D., resigned as members of the Company’s Board.
effective August 1, 2024, Jonathan Ireland has resigned from the Company’s Board of Directors
Jonathan Gear, Chief Executive Officer of Clarivate Plc (the “Company”) will depart from his position and step down as a member of the board of directors (the “Board”), effective August 9, 2024.
On August 5, 2024, Matteo Anversa notified Gentherm Incorporated (the “Company”) of his voluntary resignation as Executive Vice President of Finance, Chief Financial Officer and Treasurer of the Company (collectively, “CFO”), effective September 1, 2024 (the “Separation Date”).
On August 1, 2024, Tony D. Whitaker notified Kentucky First Federal Bancorp (the “Company”) that he will retire as Chairman of the Company and as Chairman of First Federal Savings Bank of Kentucky (“First Federal of Kentucky”), effective August 1, 2024.
On July 31, 2024, Mr. Haotian Song resigned from his position as a vice president of Singularity Future Technology Ltd. (the “ Company ”) and as a director of the board of directors of the Company (the “ Board ”).
On July 31, 2024, Mr. Haotian Song resigned from his position as a vice president of Singularity Future Technology Ltd. (the “ Company ”) and as a director of the board of directors of the Company (the “ Board ”).
On August 6, 2024, Under Armour, Inc. (the “Company”) announced that Jim Dausch, who joined the Company as Chief Consumer Officer in July 2023 and was a named executive officer in the Company’s most recent proxy statement, will be leaving the Company on August 30, 2024 to pursue other opportunities.
Jerry Lewin resigned from his position as a member of the board of directors of the company on August 2, 2024, effective immediately.
On August 6, 2024, the Company announced the departure of Shenif Visram as the Company’s Chief Financial Officer, effective as of the close of business on August 20, 2024, for personal, family-related reasons.
the Company and Eric O’Toole, President, North America, have agreed to mutually part ways pursuant to a Separation Agreement and General Release
As previously announced, the Company’s and the Company’s former Chief Financial Officer, Jeffrey Ishmael, entered into a Separation Agreement, pursuant to which Mr. Ishmael’s last day of employment will be August 31, 2024.
the Company entered into a transition agreement (the “Transition Agreement”) and a consulting agreement (the “Consulting Agreement”) with the Company’s Chief Financial Officer, Tom Fitzgerald, in order to provide the Company additional time to identify, retain and onboard its next Chief Financial Officer.
The Separation Agreement provides that Ms. Carlisle’s employment with the Company will end December 31, 2024 or such earlier date as she or the Company may determine (the “Effective Date”).
The Company announced on August 6, 2024 that Stephan D. Scholl will step down as the Company’s Chief Executive Officer (“CEO”) and as a director on the Company’s board of directors (the “Board”), effective after the Board names a successor.
On August 3, 2024, Jeremy Hitchcock delivered notice of his resignation as co-Chief Executive Officer and a member of the Board effective immediately.
On August 5, 2024, Marc Thompson informed the Company of his resignation as Chief Financial Officer to pursue other opportunities, effective September 6, 2024
upon Mr. Smith’s previously announced retirement from that position
Lawrence W. Stranghoener provided notice to the Company that he does not intend to run for re-election to the Board at the Annual Meeting of Shareowners to be held in October 2024. He will retire from the Board at the end of that meeting.
succeeds Gregory Harwell, who no longer serves in that position.
On July 31, 2024, the Company announced that George R. Oliver, its Chairman and Chief Executive Officer, has informed the Board of his plan to retire and requested that the Board initiate the Company’s Chief Executive Officer succession plan.
On August 1, 2024, Dr. Susan Altschuller notified Mural Oncology plc (the “Company”) of her decision to resign as a member of the Board of Directors of the Company (the “Board”) and all committees of the Board on which she serves, effective as of September 1, 2024.
the Company announced that Robert Spence was retiring and resigned his position of Senior Vice President, General Counsel, and Secretary effective August 1, 2024.
Mr. Andy Yeung notified the Company that he intends to resign as Chief Financial Officer of the Company. Mr. Yeung will step down from the position of Chief Financial Officer, effective September 30, 2024.
each of the following directors of the Company (Irwin D. Simon, Anuraag Agarwal, Steven M. Cohen, Denise M. Faltischek, Michael F. Goss and Ira J. Lamel) resigned as a member of the board of directors of the Company as of the Effective Time.
each of the following directors of the Company (Irwin D. Simon, Anuraag Agarwal, Steven M. Cohen, Denise M. Faltischek, Michael F. Goss and Ira J. Lamel) resigned as a member of the board of directors of the Company as of the Effective Time.
each of the following directors of the Company (Irwin D. Simon, Anuraag Agarwal, Steven M. Cohen, Denise M. Faltischek, Michael F. Goss and Ira J. Lamel) resigned as a member of the board of directors of the Company as of the Effective Time.
each of the following directors of the Company (Irwin D. Simon, Anuraag Agarwal, Steven M. Cohen, Denise M. Faltischek, Michael F. Goss and Ira J. Lamel) resigned as a member of the board of directors of the Company as of the Effective Time.
each of the following directors of the Company (Irwin D. Simon, Anuraag Agarwal, Steven M. Cohen, Denise M. Faltischek, Michael F. Goss and Ira J. Lamel) resigned as a member of the board of directors of the Company as of the Effective Time.
each of the following directors of the Company (Irwin D. Simon, Anuraag Agarwal, Steven M. Cohen, Denise M. Faltischek, Michael F. Goss and Ira J. Lamel) resigned as a member of the board of directors of the Company as of the Effective Time.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.